We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291512
Recruitment Status : Completed
First Posted : February 14, 2006
Last Update Posted : October 13, 2011
Information provided by:

Study Description
Brief Summary:
This project studies the effectiveness of a sexual risk reduction intervention among HIV+ Men who have Sex with Men (MSM) and who use methamphetamine.

Condition or disease Intervention/treatment Phase
HIV Infections STDs Methamphetamine Abuse Behavioral: Theory-based counseling program Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Promoting Safer Sex in HIV+ MSM Methamphetamine Users

Arms and Interventions

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • HIV+
  • Men who have sex with men

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00291512

United States, California
HIV Neurobehavioral Research Center
San Diego, California, United States, 92103
Sponsors and Collaborators
University of California, San Diego
National Institute on Drug Abuse (NIDA)
Principal Investigator: Thomas L. Patterson, Ph.D. University of California, San Diego
More Information

ClinicalTrials.gov Identifier: NCT00291512     History of Changes
Other Study ID Numbers: DESPR DA012116
R01DA012116 ( U.S. NIH Grant/Contract )
First Posted: February 14, 2006    Key Record Dates
Last Update Posted: October 13, 2011
Last Verified: November 2008

Keywords provided by University of California, San Diego:
Methamphetamine abuse

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Central Nervous System Stimulants
Physiological Effects of Drugs
Autonomic Agents
Peripheral Nervous System Agents
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Dopamine Uptake Inhibitors